Trials / Completed
CompletedNCT01490515
Embryo Selection Using Non-invasive Metabolomic Analysis Versus Morphology
Embryo Selection Using Non-invasive Metabolomic Analysis Indicates Improvement in Implantation Rates With Fetal Cardiac Activity
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Eugonia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The investigators intended to investigate if embryo assessment using non-invasive metabolomic profiling leads to increased implantation rates compared to routine morphology evaluation alone.
Detailed description
Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The aim of the present study was to determine whether embryo selection using non-invasive metabolomic profiling as an adjunct to morphology leads to increased implantation rates compared to routine morphology evaluation alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | non-invasive metabolomic profiling | non-invasive metabolomic profiling of IVF human embryos |
| OTHER | morphological evaluation | Simple microscopic observation of embryos and evaluation of morphological characteristics |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2011-12-13
- Last updated
- 2013-12-16
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01490515. Inclusion in this directory is not an endorsement.